Formation of vascular channels from cancer stem cells (tumor cells). |
Development of new blood vessels and capillaries from pre-existing ones. |
[1,12] |
Patterned networks of interconnected loops and cords formation |
Formation by sprouting or intussusception |
[1,7] |
Formed by tumor cells and cancer stem cells |
Formed by endothelial cells |
[7] |
Aberrant expression of VE-Cadherin |
VE-Cadherin localization in cell membranes |
[13] |
PAS+, CD31−/low staining |
PAS−/low, CD31+ staining |
[7] |
Factor VIII-related antigen negative or low |
Factor VIII-related antigen highly positive |
[7] |
Unaffected by endostatin and other antiangiogenic factors |
Inhibited by antiangiogenic factors |
[14,15] |
EPHA2, TIE1, LAMC2, overexpression |
EPHA2, TIE1, LAMC2 generally negative. |
[16] |
Express stemness markers, e.g., CD133, ALDH1 |
CD133 positivity mostly in endothelial precursor cells |
[17,18,19,20] |
More abundant in poorly differentiated tumors, such as HER2+ and TNBC |
Present in embryogenesis, wound healing and tumor growth |
[16,21] |